Prestige Consumer Healthcare (PBH) Net Income towards Common Stockholders Growth (1y) (2011 - 2025)
Prestige Consumer Healthcare (PBH) Net Income towards Common Stockholders Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | -304.98% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | -5.04% |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | -17.29% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 7.59% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -2,482.61% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 34.33% |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | 390.91% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.43 Bn | 2.36 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -23.49% |
| Sep 30, 2025 | -22.37% |
| Jun 30, 2025 | -3.26% |
| Mar 31, 2025 | 1.35% |
| Dec 31, 2024 | 15.05% |
| Sep 30, 2024 | 1.53% |
| Jun 30, 2024 | -7.90% |
| Mar 31, 2024 | 120.56% |
| Dec 31, 2023 | 2.11% |
| Sep 30, 2023 | 4.97% |
| Jun 30, 2023 | -3.61% |
| Mar 31, 2023 | -561.84% |
| Dec 31, 2022 | 3.46% |
| Sep 30, 2022 | 12.57% |
| Jun 30, 2022 | -4.30% |
| Mar 31, 2022 | 46.66% |
| Dec 31, 2021 | 22.86% |
| Sep 30, 2021 | 1.65% |
| Jun 30, 2021 | 32.14% |
| Mar 31, 2021 | -4.14% |